COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 1394: Articles 13931-13940  | Next

COVID-19 in Londrina-PR-Brazil: SEIR Model with Parameter Optimization
Cirilo, E. R., Natti, P. L., Godoi, P. H., Lerma, A. A., Matias, V. P., Romeiro, N. M.
10.1101/2021.07.27.21261227 — Posted: 2021-07-30
Statistical Analysis Plan for the Helmet Non-Invasive Ventilation for COVID-19 Patients (Helmet-COVID) Randomized Controlled Trial
Arabi, Y., Tlayjeh, H., Aldekhyl, S., Al-Dorzi, H., Abdukahil, S., Jose, J., Al Harbi, M. K., Al Haji, H., Al Mutairi, M., Al Zumai, O., Al Qasim, E., Al Wehaibi, W., Al Qahtani, S., Alshahrani, M., Albrahim, T., Mady, A., Bshabshe, A., Al Aseri, Z., Al Duhailib, Z., Kharaba, A., Alqahtani, R., Algethamy, H., Alfaris, O., Alnafel, O., Al-Fares, A.
10.1101/2021.07.26.21260421 — Posted: 2021-07-30
Purifying selection determines the short-term time dependency of evolutionary rates in SARS-CoV-2 and pH1N1 influenza
Ghafari, M., du Plessis, L., Raghwani, J., Bhatt, S., Xu, B., Pybus, O., Katzourakis, A.
10.1101/2021.07.27.21261148 — Posted: 2021-07-30
Amygdala connectivity as a predisposing neural feature of stress-induced behaviour during the COVID-2019 outbreak in Hubei
Zhou, Y., He, Y., Jin, Y., Rong, B., Zeidman, P., Huang, H., Feng, Y., Cui, J., Zhang, S., Wang, Y., Wang, G., Xiang, Y., Wang, H.
10.1101/2021.07.26.21261160 — Posted: 2021-07-30
A regression discontinuity analysis of the social distancing recommendations for older adults in Sweden during COVID-19
Bonander, C., Stranges, D., Gustavsson, J., Almgren, M., Inghammar, M., Moghaddassi, M., Nilsson, A., Franks, P. W., Gomez, M. F., Fall, T., Bjork, J., COVID Symptom Study Sweden
10.1101/2021.07.22.21260973 — Posted: 2021-07-30
Data Analysis and Forecasting of COVID-19 Pandemic in Kuwait
Oshinubi, K., Al-Awadhi, F., Rachdi, M., Demongeot, J.
10.1101/2021.07.24.21261059 — Posted: 2021-07-30
Measuring odds of various COVID-19 infection prevention & control measures among the contacts traced during trace test and quarantine activities at district Quetta (An un-matched case control study).
Arif, M., Larik, E., Saeed, A., Abdullah, M.
10.1101/2021.07.25.21261084 — Posted: 2021-07-30
Doxycycline is a safe alternative to Hydroxychloroquine + Azithromycin to prevent clinical worsening and hospitalization in mild COVID-19 patients: An open label randomized clinical trial (DOXYCOV)
Sobngwi, E., Zemsi, S., Guewo-Fokeng, M., Katte, J. C., Kouanfack, C., Mfeukeu-Kuate, L., Zemsi, A., Wasnyo, Y., Assiga-Ntsama, A., Ndi-Manga, J. A., Tambekou, J. S., Ngatchou, W., Moussi-Omgba, C., Mbanya, J.-C., Ongolo-Zogo, P., Fouda, P.-J.
10.1101/2021.07.25.21260838 — Posted: 2021-07-29
SARS-CoV-2 exposure in wild white-tailed deer (Odocoileus virginianus)
Chandler, J. C., Bevins, S. N., Ellis, J. W., Linder, T. J., Tell, R. M., Jenkins-Moore, M., Root, J. J., Lenoch, J. B., Robbe-Austerman, S., DeLiberto, T. J., Gidlewski, T., Torchetti, M. K., Shriner, S. A.
10.1101/2021.07.29.454326 — Posted: 2021-07-29 Discussion: Onsite | Offsite
Antibody Evolution after SARS-CoV-2 mRNA Vaccination
Cho, A., Muecksch, F., Schaefer-Babajew, D., Wang, Z., Finkin, S., Gaebler, C., Ramos, V., Cipolla, M., Agudelo, M., Bednarski, E., DaSilva, J., Shimeliovich, I., Dizon, J., Daga, M., Millard, K., Turroja, M., Schmidt, F., Zhang, F., Ben Tanfous, T., Jankovic, M., Oliveira, T., Gazumyan, A., Caskey, M., Bieniasz, P. D., Hatziioannou, T., Nussenzweig, M. C.
10.1101/2021.07.29.454333 — Posted: 2021-07-29 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).